GenScript and BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan
GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK), a leading global biotechnology company, and BioComo Incorporation, a drug discovery venture based in Mie prefecture, Japan, today announces a strategic agreement for joint research and development project on GenScript’s cPass™ SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit as the in vitro neutralization assay of a BC-PIV derived SARS-Cov-2 […]
